Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0R1D stock hub

LON/0R1D has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0R1Dis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

35M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0R1D

In the news

Latest news · LON/0R1D

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-2,891.8

P25 -54.2P50 2.1P75 13.7

ROIC-205

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0R1D market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

164

Groups with data

Currency

USD

Showing 164 of 164 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	142
Employees Change	-222%
Employees Change Percent	-54.81
Enterprise value	$39.3M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US8006771062
Last refreshed	2026-05-10
Market cap	$35M
Price	$0.12
Price currency	USD
Rev Per Employee	206,951.66x
Sector	Healthcare
Sic	2836
Symbol	lon/0R1D
Website	https://www.sangamo.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-261.24%
EV Earnings	-0.43x
EV/FCF	-0.54x
EV/Sales	1.35x
FCF yield	-206.79%
P/B ratio	-3.3x
P/S ratio	1.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-273.07%
EBITDA Margin	-263.05%
Gross margin	-184.87%
Gross Profit	$-54.3M
Net Income	$-91.3M
Net Income Growth Years	0%
Pretax Margin	-312.25%
Profit Per Employee	$-643,229
ROA	-83.66
Roa5y	-36.54
ROCE	-625.1
ROE	-2,891.8
Roe5y	-662.4
ROIC	-205

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-80.79%
Cagr3y	-56.26%
Cagr5y	-59.11%
EPS Growth Years	2
Revenue Growth	-31.57x
Revenue Growth Q	88.43x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-29.17x
Revenue Growth5 Y	-19.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.49
Assets	$44.4M
Cash	$15.6M
Current Assets	$26.3M
Current Liabilities	$31.1M
Debt	$19.9M
Debt FCF	$-0.28
Equity	$-10.6M
Liabilities	$55M
Long Term Assets	$18.1M
Long Term Liabilities	$23.8M
Net Cash	$-4.3M
Net Cash By Market Cap	$-12.43
Tangible Book Value	$-10.6M
Tangible Book Value Per Share	$-0.03
WACC	6.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.84
Net Working Capital	$-19.2M
Quick ratio	0.74
Working Capital	$-4.9M
Working Capital Turnover	$-78.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-38.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-80.77%
200-day SMA	0.45
3Y total return	-91.64%
50-day SMA	0.29
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.86%
All Time High	26.35
All Time High Change	-99.56%
All Time High Date	2018-03-12
All Time Low	0.1
All Time Low Change	15.34%
All Time Low Date	2026-05-08
ATR	0.04
Beta	1.04
Ch YTD	-72.02
High	0.12
High52	0.77
High52 Date	2025-10-10
High52ch	-84.96%
Low	0.1
Low52	0.1
Low52 Date	2026-05-08
Low52ch	14.54%
Ma50ch	-60.08%
Price vs 200-day SMA	-74.5%
RSI	35.43
RSI Monthly	35.09
RSI Weekly	28.85
Sharpe ratio	-0.69x
Sortino ratio	-0.91
Total Return	-38.92%
Tr YTD	-72.02
Tr1m	-54.73%
Tr1w	-9.74%
Tr3m	-69.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-80.2M
Operating margin	-273.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	406,773,088%
Shares Qo Q	11%
Shares Yo Y	38.92%
Short Ratio	4.25

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-79M
Average Volume	432,228.55x
Bv Per Share	-0.03
CAPEX	$-75,786
Ch1m	-54.73
Ch1w	-9.74
Ch1y	-80.77
Ch3m	-69.42
Ch3y	-91.64
Ch5y	-98.86
Ch6m	-75.22
Change	5.85%
Change From Open	10.29
Close	0.11
Days Gap	-4.02
Depreciation Amortization	2,905,449
Dollar Volume	104,599.2
Earnings Date	2026-05-14
EBIT	$-80.2M
EBITDA	$-77.3M
EPS	$-0.33
F Score	2
FCF	$-72.3M
FCF EV Yield	-184.19x
Financing CF	52,566,507
Fiscal Year End	December
Founded	1,995
Income Tax	$-422,024
Investing CF	-75,786
Is Primary Listing	0
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Ma150	0.42
Ma150ch	-72.59%
Ma20	0.2
Ma20ch	-42.27%
Net CF	-16,695,210
Next Earnings Date	2026-05-14
Open	0.11
Position In Range	68.14
Ppne	10,346,948.5
Price Date	2026-05-08
Relative Volume	2.33x
Revenue	29,387,136x
SBC By Revenue	22.95x
Share Based Comp	6,745,697
Tax By Revenue	-1.44x
Tr6m	-75.22%
Volume	903,275
Z Score	-42.19

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0R1D pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0R1D stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0R1D?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0R1D momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

35.4

Neutral momentum band

Price vs 200-day MA

-74.5%

50/200-day relationship not available

Beta (5Y)

1.04

Moves roughly with the market

Sharpe ratio

-0.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0R1D

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R1D stock rating?

lon/0R1D is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R1D analysis?

The full report lives at /stocks/lon/0R1D/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R1D?

The latest report frames lon/0R1D around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R1D page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.